Canada's rare disease landscape presents a unique opportunity to revolutionize healthcare through a learning health ecosystem. With a strong foundation in genomics and data infrastructure, the country can create a more integrated and effective system for managing rare diseases, but it requires a strategic approach to unlock its full potential.
The article emphasizes the importance of data sharing for accurate diagnoses, highlighting the role of the All for One Data Sharing Agreement and the Canadian Open Genetics Repository in enabling responsible data exchange. It also underscores the need for discovery research to identify new disease-gene relationships, with initiatives like Care4Rare and the Pan-Canadian Genome Library playing a crucial role. However, the current fragmentation of efforts and short-term funding cycles hinder progress.
To address these challenges, the author proposes a federated approach, where data remains within trusted institutions while being discoverable and comparable through shared standards and governance. This aligns with the Pan-Canadian Health Data Strategy's call for stronger data foundations. The article emphasizes the need for federal leadership, recognizing that healthcare administration varies across provinces and territories. It suggests that Canada should follow the lead of countries like England, Australia, and Denmark, which have invested heavily in genomic medicine and health data infrastructure.
The author also stresses the importance of recognizing data sharing as core diagnostic infrastructure, integrating the costs of responsible data sharing, interoperability, and legal/data governance support into funding models. Establishing national standards for rare disease testing and data is crucial, including clear requirements for publicly funded genomic testing, laboratory accreditation, and professional certification. Standardized data collection across phenotype, genotype, variant interpretation, consent, and outcomes is essential for seamless data sharing.
Furthermore, the article highlights the need for patient, family, and community involvement in governance. Trust in data sharing can be built by ensuring transparency, security, and alignment with patient priorities. The author concludes that Canada's rare disease management can be significantly improved by treating data sharing as core health infrastructure, supported by sustained investment, policy alignment, and coordination across jurisdictions and sectors. This approach will strengthen the system for all patients, making it a model for other countries to follow.
